Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
3.360
+0.010 (0.30%)
At close: Dec 5, 2025, 4:00 PM EST
3.400
+0.040 (1.19%)
After-hours: Dec 5, 2025, 7:59 PM EST
Genprex Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -17.05 | -21.39 | -30.86 | -23.74 | -20.66 | -17.94 | |
| Depreciation & Amortization | 0 | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Stock-Based Compensation | 0.96 | 3.3 | 5.41 | 4.73 | 5.35 | 4.25 | |
| Other Operating Activities | 1.51 | 1.05 | - | - | - | - | |
| Change in Accounts Receivable | - | - | 0.03 | -0.03 | 0 | 0 | |
| Change in Accounts Payable | 0.32 | -0.32 | 0.95 | -0.53 | 0.78 | -0.25 | |
| Change in Other Net Operating Assets | -0.05 | 0.2 | -0.29 | 1.93 | 0.23 | -0.01 | |
| Operating Cash Flow | -14.31 | -17.15 | -24.74 | -17.62 | -14.28 | -13.94 | |
| Capital Expenditures | - | - | - | - | -0.03 | -0.02 | |
| Sale of Property, Plant & Equipment | -0 | 0 | 0 | - | - | - | |
| Sale (Purchase) of Intangibles | -0.77 | - | -0.07 | -0.06 | -0.05 | -2.32 | |
| Investing Cash Flow | -0.77 | 0 | -0.07 | -0.06 | -0.08 | -2.34 | |
| Issuance of Common Stock | 14.7 | 12.01 | 10.59 | 0.01 | 25.68 | 41.59 | |
| Financing Cash Flow | 14.7 | 12.01 | 10.59 | 0.01 | 25.68 | 41.59 | |
| Net Cash Flow | -0.38 | -5.14 | -14.22 | -17.67 | 11.31 | 25.32 | |
| Free Cash Flow | -14.31 | -17.15 | -24.74 | -17.62 | -14.32 | -13.95 | |
| Free Cash Flow Per Share | -31.85 | -214.04 | -904.35 | -734.93 | -607.95 | -785.58 | |
| Levered Free Cash Flow | -10.18 | -10.36 | -13.89 | -8.98 | -6.62 | -8.76 | |
| Unlevered Free Cash Flow | -9.89 | -10.36 | -13.89 | -8.98 | -6.62 | -8.76 | |
| Change in Working Capital | 0.27 | -0.12 | 0.7 | 1.36 | 1.01 | -0.26 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.